Csl (QX) 주식 가격. CSLLY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

가격

87.76

매수가

87.74

매도가

88.02

거래량

24,027

87.045 일간 변동폭 89.69

83.31 52주 범위 109.00

market_cap

84.821B

전일 종가

86.23

개장가

89.69

최근 거래 시간

87.74

마지막 거래 시간

02:05:57

재정 규모

US$ 2,102,500

VWAP

87.5057

평균 볼륨(3m)

88,012

발행 주식

966,505,458

배당수익률

주가수익률

102.41

주당순이익(EPS)

2.73

매출

14.69B

순이익

2.64B

CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology.

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.csl.com.au

본부

Melbourne, Victoria, Aus

설립됨

1916

Csl Ltd (QX) is listed in the Biological Pds,ex Diagnstics sector of the OTC 시장 with ticker CSLLY. The last closing price for Csl (QX) was US$86.23. Over the last year, Csl (QX) shares have traded in a share price range of US$ 83.31 to US$ 109.00.

Csl (QX) currently has 966,505,458 shares in issue. The market capitalisation of Csl (QX) is US$83.34 billion. Csl (QX) has a price to earnings ratio (PE ratio) of 102.41.

Form 3 - Initial statement of beneficial ownership of securities

CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient

CSL Behring Announces the 2015 Interlaken Leadership Awards Recipient Awards Program Supports Novel Research of Immunoglobulin Therapy for Neurological Disorders PR Newswire KING OF PRUSSIA, Pa...

CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015

CSL Behring Presents rIX-FP for Hemophilia B Phase III Data Evaluating Efficacy, Safety and Improved Dosing at ISTH 2015 PR Newswire TORONTO, June 24, 2015 - Data supports prolonged dosing...

CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A

CSL Behring Announces Pivotal Data of Novel rVIII-SingleChain Therapy in Adolescents and Adults with Hemophilia A PR Newswire TORONTO, June 24, 2015 Data Presented during Late Breaking Session at...

Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers

Defining And Differentiating The Value Of Therapies Used To Treat Rare Disease Patients Is A Challenge For Payers Panel of experts examines how value of biopharmaceutical technologies is assessed...

CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress

CSL Behring to Present Pivotal Data for rVIII-SingleChain and rIX-FP at 2015 ISTH Congress PR Newswire KING OF PRUSSIA, Pa., June 16, 2015 More than 20 abstracts focusing on investigational and...

Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients...

Important New Findings Published in The Lancet Support the Use of Zemaira® [Alpha1-Proteinase Inhibitor (Human)] in Patients with Alpha-1 Antitrypsin Deficiency (AATD) PR Newswire KING OF...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	3.01	3.55162241888	84.75	89.69	84.49	92654	85.37390566	DR
4	0.294	0.336130610752	87.466	90.04	83.51	89365	86.54011522	DR
12	-7.0205	-7.40711433259	94.7805	95.1	83.31	88012	88.35119378	DR
26	-14.016	-13.7714195881	101.776	109	83.31	50685	91.03483501	DR
52	-9.24	-9.52577319588	97	109	83.31	41304	92.17507466	DR
156	-1.2901	-1.44873503792	89.0501	110.25	71.51	65767	91.49439518	DR
260	-17.22	-16.4031244046	104.98	117.98	71.51	58836	95.48862095	DR

CSLLY - Frequently Asked Questions (FAQ)

What is the current Csl (QX) share price?

The current share price of Csl (QX) is US$ 87.76

How many Csl (QX) shares are in issue?

Csl (QX) has 966,505,458 shares in issue

What is the market cap of Csl (QX)?

The market capitalisation of Csl (QX) is USD 83.34B

What is the 1 year trading range for Csl (QX) share price?

Csl (QX) has traded in the range of US$ 83.31 to US$ 109.00 during the past year

What is the PE ratio of Csl (QX)?

The price to earnings ratio of Csl (QX) is 102.41

What is the cash to sales ratio of Csl (QX)?

The cash to sales ratio of Csl (QX) is 18.42

What is the reporting currency for Csl (QX)?

Csl (QX) reports financial results in USD

What is the latest annual turnover for Csl (QX)?

The latest annual turnover of Csl (QX) is USD 14.69B

What is the latest annual profit for Csl (QX)?

The latest annual profit of Csl (QX) is USD 2.64B

What is the registered address of Csl (QX)?

The registered address for Csl (QX) is 45 POPLAR ROAD, PARKVILLE, MELBOURNE, VICTORIA, 3052

What is the Csl (QX) website address?

The website address for Csl (QX) is www.csl.com.au

Which industry sector does Csl (QX) operate in?

Csl (QX) operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0.008 (799,900.00%)	318
RLLVFRelevium Technologies Inc (CE)	US$ 0.008 (799,900.00%)	8k
NTBLQNotable Labs Ltd (CE)	US$ 0.0199 (19,800.00%)	21.96k
SIRCSolar Integrated Roofing Corporation (PK)	US$ 0.0001 (9,900.00%)	5.33M
MRPIMera Pharmaceuticals Inc (CE)	US$ 0.0001 (9,900.00%)	4.57M
ISUNQiSun Inc (CE)	US$ 0.000001 (-99.90%)	200
JFTHJapan Food Tech Holdings Inc (CE)	US$ 0.000001 (-99.50%)	400
JAMNJammin Java Corp (PK)	US$ 0.000001 (-99.00%)	156.25k
SGMDSugarmade Inc (CE)	US$ 0.000001 (-99.00%)	6.1k
INTKIndustrial Nanotech Inc (PK)	US$ 0.000001 (-99.00%)	28.06k
GRLFGreen Leaf Innovations Inc (PK)	US$ 0.0002 (100.00%)	201.71M
GMPRGourmet Provisions International Corporation (PK)	US$ 0.0001 (0.00%)	70.98M
DRNKNoHo Inc (PK)	US$ 0.0001 (0.00%)	65.51M
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0.00285 (-5.00%)	61.78M
THBDThird Bench Inc (PK)	US$ 0.0001 (-33.33%)	60.99M